helping hematologists conquer blood diseases
About ASH | Patients | Media | Make a Gift | Corporate Supporters
Home > Education > Teach case > Quinn >
  E-Mail This Page | Print This Page
MembershipMeetingsPublicationsEducation & CareersPolicy & PracticeASH Store


Find a Hematologist
Hematology Library

Blood
Image Bank
Education Program Book
ASH-SAP
Abstract Search
 
Teaching Cases

Anemia and Jaundice in a Newborn – Charles T. Quinn, MD
UT Southwestern Medical Center, Dallas, TX

Copyright of the American Society of Hematology, 2006. ISSN: 1931-6860.


I. HistoryII. Physical ExamIII. Laboratory DataIV. Differential Diagnosis
V. PathophysiologyVI. Prognosis/Clinical CourseVII. Teaching PointsVIII. Bibliography

VII. TEACHING POINTS

  • The most important blood group system is the ABO group. Individuals can be type A, B, AB, or O.
  • The Rh blood group is a complex system that includes the major D antigen and the antigens of the CcEe series, among others. The presence or absence of the major D antigen determines whether an individual is Rh-positive (D present) or negative (D absent).
  • Alloimmunization is an immune response directed against foreign antigens that are expressed by other members of the same species. Alloimmunization can occur, for example, as a consequence of allogeneic blood transfusion or pregnancy (hemolytic disease of the newborn). In the context of this teaching case, alloimmunization refers to the formation by the mother of antibodies (alloantibodies) against fetal erythrocyte antigens, to which she is sensitized during pregnancy.
  • Isohemagglutinins are naturally occurring antibodies with specificity against the A and B antigens of the ABO blood group. These antibodies are typically IgM-class antibodies in group A and B individuals and IgG-class in type O individuals.
  • Hemolytic disease of the newborn (HDN) is classically caused by Rh (D) alloimmunization, but this form of the disease has become much less common in the developed world because of the preventive use of anti-D immunoglobulin (RhoGAM) in D- negative women. Nevertheless, Rh HDN has not been eliminated.
  • HDN due to ABO isohemagglutinins is now more common than Rh (D) alloimmunization, but it is typically restricted to group A or B neonates of group O mothers. This occurs because group O individuals make predominantly IgG (rather than IgM) anti-A and anti-B isohemagglutinins, which can cross the placenta. Blood group A or B mothers produce predominantly IgM isohemagglutinins that do not cross the placenta. The anemia that occurs in ABO HDN tends to be mild, but the peripheral smear may show marked spherocytosis, nevertheless.
  • Fetomaternal mismatches for many minor blood group antigens (non-ABO, non-D) can also cause HDN. Commonly implicated minor antigens include: K1 (Kell), c (Rh), and Fya (Duffy). These minor antigens are now the most common cause of HDN in areas of the world where Rho-GAM is available.
  • HDN is a transient disease that lasts approximately 1-3 months, depending on the antibody concentration and rate of hemolysis.
  • A neonate should receive red blood cells that are compatible with both the neonate’s blood group and the mother’s blood group. Generally transfused red blood cells are O-, but they must also be crossmatch compatible with maternal serum. Thus, transfusion of O- red blood cells, without further characterization and crossmatching, may be inappropriate in cases of HDN.

Have a question or comment about the ASH Teaching Cases? Please e-mail webmaster@hematology.org.

 

 

Contact Us   |   Terms of Use   |   Photo Credit   |   RSS

1900 M Street, NW, Suite 200    Washington, DC 20036    Phone: 202-776-0544    Fax: 202-776-0545    E-mail: ash@hematology.org

©2008 American Society of Hematology